Complex activation of inducible transcription factors in the brain of normotensive and spontaneously hypertensive rats following central angiotensin II administration

Regulatory Peptides

Volumn 66, Issue 1-2, 1996, Pages 19-23

  Lebrun, C J ^a,b   Blume, A ^a,b   Herdegen, Th ^c   Mollenhoff E ^a,b   Unger, Th ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b German Institute for High Blood Pressure Research   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin II; AT1 receptor; Central nervous system; Inducible transcription factor; Normotensive rat; Spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CAPTOPRIL; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR BIOLOGY; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030575636     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(96)00046-8     Document Type: Article

References (33)

1. [1] Almendral, J.M., Somner, D., Macdonald-Bravo H., Burckhardt J., Perrera, J. and Bravo, R., Complexity of the early genetic response to growth factors in mouse fibroblasts, Mol. Cell. Biol., 8 (1988) 2140-2148.
2. [2] Blume, A., Lebrun, C.J., Herdegen, T., Bravo. R., Möllenhoff, E. and Unger, Th., Angiotensin II induces an increased expression of inducible transcription factors in the brain of spontaneously hypertensive rats, Hypertension (1995) in press
3. [3] Beagley, G.H. and Hatton, G.I., Rapid morphological changes in supraoptic nucleus and posterior pituitary induced by a single hypertonic saline injection, Brain Res., 28 (1992) 613-618
4. [4] Bravo, R., Growth factor inducible genes in fibroblasts, In: Habenicht, A. (Ed.), Growth Factors, Differentiation Factors and Cytokinines, Vol. 618. Springer, Berlin, 1990, pp. 324-343.
5. [5] Culman, J., Höhle, S., Qadri, F., Edling, O., Blume, A., Lebrun, C.J. and Unger, Th., Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasis, Clin. Exp. Hypertens., 17 (1995) 281-293.
6. [6] Geistefehr, A.A.T., Peach, M.J. and Owens, G.K., Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells, Circ. Res., 62 (1988) 749-756.
7. [7] Hengerer, B., Lindholm, D., Heumann, R., Rüther, U., Wagner, E.F. and Thoenen, H., Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl. Acad. Sci. USA, 87 (1990) 3899-3903.
8. [8] Herbert, J., Forsling, M.L., Howes, S.R., Stacey, P.M. and Shiers, H.M., Regional expression of c-fos antigen in the basal forebrain following intraventricular infusion of angiotensin and its modulation by drinking either water or saline, Neuroscience, 51 (1992) 867-882.
9. [9] Herdegen, Th. and Zimmermann, M., Expression of c-Jun and JunD transcription factors represent specific changes in neuronal gene expression following axotomy, Prog. Brain Res., 103 (1994) 153-171.
10. [10] Hogarty, D.C., Tran, D.N. and Philipps, I., Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin, Brain Res., 637 (1994) 126-132.
11. [11] Höhle, S., Blume, A., Lebrun, C.J., Culman, J. and Unger, Th., Angiotensin receptors in the brain, Pharmacol. Toxicol. (1995) in press.
12. [12] Inagami, T., Mizukoshi, M. and Guo, D.-F., Angiotensin II receptor. Molecular cloning, functions, and regulation. In: Saavedra, J.M. and Timmermans, P.B.M.W.M. (Eds.), Angiotensin Receptors. Plenum Press, New York, NY, 1994.
13. [13] Lebrun, C.J., Möllenhoff, E., Bao, G., Culman, J. and Unger, Th., Angiotensin II induces the expression of c-fos mRNA in the central nervous system, Clin. Exp. Hypertens., 17 (1995) 877-893
14. [14] Lebrun, C.J., Blume, A., Herdegen, Th., Seifert, K., Bravo, R. and Unger, Th., Angiotensin II induces a complex activation of transcription factors in the rat brain: Expression of Fos, Jun and Krox proteins, Neuroscience, 65 (1995) 93-99.
15. 1 receptor, J. Hypertens., 10 (1992) 1463-1469.
16. [16] Massod, K., Besnard F., Su, Y., Brenner, N., Analysis of a segment of the human glial fibrillary acidic protein gene that directs astrocyte-specific transcription. J. Neurochem., 87 (1993) 160-166.
17. [17] McKinley, M.J., Badoer, E. and Oldfield, B.J., Intravenous angiotensin II induces Fos-immunoreactivity in circumventricular organs of the lamina terminalis, Brain Res., 594 (1992) 295-300.
18. [18] Mohr, E. and Richter, D., Sequence analysis of the promoter region of the rat vasopressin gene, FEBS Lett., 260 (1990) 305-308.
19. [19] Morgan, J.I. and Curran, T., Inducible proto-oncogenes of the nervous system: their contribution to transcription factors and neuroplasticity, Prog. Brain Res., 86 (1990) 287-294.
20. [20] Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Rev. Neurosci., 14 (1991) 421-451.
21. [21] Paquet, J.L., Baudouin-Legros, M., Brunelle, G. and Meyer, P., Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats, J. Hypertens., 8 (1990) 565-572.
22. [22] Paul, M. and Ganten, D., The molecular basis of cardiac hypertrophy: the role of the renin angiotensin system, J. Cardiovasc. Pharmacol., 19 (Suppl. 5) (1992) S51-S58.
23. [23] Philips, M.I., Functions of angiotensin in the central nervous system, Annu. Rev. Physiol., 49 (1987) 413-435.
24. 1 receptors in the supraoptic nucleus, J. Pharmacol. Exp. Ther., 257 (1993) 567-574.
25. [25] Qadri, F., Edling, O., Wolf, A., Gohlke, P., Culman, J. and Unger, Th., Release of angiotensin in the paraventricular in response to hyperosmotic stimulation in conscious rats: a microdialysis study, Brain Res., 637 (1994) 45-49.
26. [26] Rowland, N.E., Li, B.A., Rozelle, A.K., Fregly, M.J., Garcia, M. and Smith, G.C., Localization of changes in immediate early genes in brain in relation to hydromineral balance: Intravenous angiotensin II, Brain Res. Bull., 33 (1994) 427-436.
27. [27] Rowland, N.E., Li, B.A., Rozelle, A.K. and Smith, G.C., Comparison of Fos-like immunreactivity induced in rat brain by central injection of angiotensin II and carbachol, Am. J. Physiol., 267 (1994) R792-R798.
28. [28] Rowland, N.E., Li, B.A., Fregly, M.J. and Smith, G.C., Fos induced in brain of spontaneously hypertensive rats by angiotensin II and co-localization with AT-1 receptors, Brain Res., 675 (1995) 127-134.
29. [29] Sharp, F.R., Sager, S., Hicks, Lowenstein, D. and Hisanaga, K., c-fos mRNA, Fos and Fos-related antigen induction by hypertonic saline and stress, J. Neurosci., 11 (1991) 2321-2331.
30. [30] Unger, Th., Badoer, E., Ganten, D., Lang, R.E. and Rettig, R., Brain angiotensin: pathways and pharmacology, Circulation, 77 (Suppl. 1) (1988) 1-40.
31. [31] Veltmar, A., Culman, J., Qadri, F., Rascher, W. and Unger, Th., Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release, J. Pharmacol. Exp. Ther., 263 (1992) 1253-1260.
32. [32] Xu, Z. and Herbert, J., Regional suppression by water intake of c-fos expression induced by intraventricular infusions of angiotensin II, Brain Res., 659 (1994) 157-168.
33. [33] Zimmermann, M. and Herdegen, Th., Control of gene transcription by Jun and Fos proteins in the nervous system. Beneficial or harmful molecular mechanisms of neuronal response to noxious stimulation?, Am. Pharmacol. Soc. J., 3 (1994) 3-48.